标普和纳斯达克内在价值 联系我们
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← 返回所有股票

Fennec Pharmaceuticals Inc. FENC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
54/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+188%

共有 50 笔近期内部人交易记录记录，涉及 Fennec Pharmaceuticals Inc. (FENC), 包括 34 笔买入 和 16 笔卖出. 内部人买入总额为 $280.29K 内部人卖出总额为 $11.01M.

近期活跃的重要内部人包括 Raykov Rosty, Andrade Robert, Hackman Jeffrey S.. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — FENC

日期 姓名 职位 交易类型 股数 平均价格 总价值 持股数量
2026-04-01 Raykov Rosty Director 知情卖出 10,946 $6.31 $69.07K 113,856
2026-03-31 Andrade Robert Chief Financial Officer 期权行权 14,724 - - 271,380
2026-03-31 Raykov Rosty Director 限制性股票授予 (RSU) 5,208 - - 109,204
2026-03-31 Hackman Jeffrey S. Chief Executive Officer 期权行权 16,695 - - 45,405
2026-03-31 Evans Terry L Chief Commercial Officer 期权行权 18,456 - - 18,456
2026-03-31 Sayad Pierre Sargis Chief Medical Officer 期权行权 18,456 - - 18,456
2026-03-31 Cioffi Christiana Marie Chief Strategy Officer 期权行权 17,106 - - 21,806
2026-03-28 Andrade Robert Chief Financial Officer 期权行权 12,270 - - 285,863
2026-03-28 Hackman Jeffrey S. Chief Executive Officer 期权行权 13,943 - - 60,507
2026-03-28 Evans Terry L Chief Commercial Officer 期权行权 2,052 - - 20,679
2026-03-28 Sayad Pierre Sargis Chief Medical Officer 期权行权 2,052 - - 20,679
2026-03-28 Cioffi Christiana Marie Chief Strategy Officer 期权行权 1,901 - - 23,865
2026-03-26 Andrade Robert Chief Financial Officer 期权行权 13,072 $5.10 $66.67K 256,656
2026-03-26 Cioffi Christiana Marie Chief Strategy Officer 期权行权 4,700 $4.23 $19.88K 4,700
2026-03-02 Raykov Rosty Director 知情卖出 10,079 $8.36 $84.26K 103,996
2026-02-28 Andrade Robert Chief Financial Officer 限制性股票授予 (RSU) 1,191 - - 243,584
2026-02-28 Raykov Rosty Director 限制性股票授予 (RSU) 5,208 - - 109,204
2026-02-18 Andrade Robert Chief Financial Officer 期权行权 2,450 $4.08 $10K 215,108
2026-02-18 Hackman Jeffrey S. Chief Executive Officer 期权行权 13,710 - - 28,710
2026-02-02 Raykov Rosty Director 知情卖出 10,349 $7.76 $80.31K 98,477
2026-01-31 Andrade Robert Chief Financial Officer 限制性股票授予 (RSU) 1,558 - - 212,658
2026-01-31 Raykov Rosty Director 限制性股票授予 (RSU) 5,208 - - 93,228
2026-01-23 Andrade Robert Chief Financial Officer 期权行权 10,000 $2.45 $24.5K 211,100
2026-01-15 Andrade Robert Chief Financial Officer 期权行权 10,000 $2.45 $24.5K 201,100
2026-01-07 Andrade Robert Chief Financial Officer 期权行权 14,184 $2.45 $34.75K 191,100
2026-01-02 Raykov Rosty Director 知情卖出 10,312 $7.60 $78.37K 88,020
2025-12-31 Andrade Robert Chief Financial Officer 限制性股票授予 (RSU) 1,382 - - 176,916
2025-12-31 Raykov Rosty Director 限制性股票授予 (RSU) 5,208 - - 82,734
2025-12-24 Southpoint Capital Advisors Lp 10 Percent Owner 知情卖出 1,000,000 $7.50 $7.5M 2,744,741
2025-12-05 Raykov Rosty Director 知情卖出 10,000 $7.54 $75.4K 77,526
2025-12-01 Andrade Robert Chief Financial Officer 限制性股票授予 (RSU) 2,430 - - 175,534
2025-12-01 Raykov Rosty Director 限制性股票授予 (RSU) 5,208 - - 87,526
2025-11-18 Southpoint Capital Advisors Lp 10 Percent Owner 知情卖出 19,341 $8.79 $170.05K 3,744,741
2025-11-17 Southpoint Capital Advisors Lp 10 Percent Owner 知情卖出 85,918 $8.79 $755.19K 3,764,082
2025-11-14 Southpoint Capital Advisors Lp 10 Percent Owner 知情卖出 160,100 $8.00 $1.28M 3,850,000
2025-11-05 Raykov Rosty Director 知情卖出 10,000 $8.10 $81K 82,318
2025-10-31 Andrade Robert Chief Financial Officer 限制性股票授予 (RSU) 2,430 - - 173,104
2025-10-31 Raykov Rosty Director 限制性股票授予 (RSU) 5,208 - - 92,318
2025-10-10 Rallis Chris A Director 知情卖出 1,775 $9.24 $16.4K 57,079
2025-10-09 Southpoint Capital Advisors Lp 10 Percent Owner 知情卖出 20,609 $9.35 $192.61K 4,010,100
2025-10-08 Raykov Rosty Director 期权行权 4,609 $2.45 $11.29K 87,110
2025-10-08 Southpoint Capital Advisors Lp 10 Percent Owner 知情卖出 19,605 $9.47 $185.72K 4,030,709
2025-10-07 Southpoint Capital Advisors Lp 10 Percent Owner 知情卖出 26,900 $9.59 $257.89K 4,050,314
2025-10-06 Raykov Rosty Director 知情卖出 10,000 $9.78 $97.8K 82,501
2025-09-30 Andrade Robert Chief Financial Officer 限制性股票授予 (RSU) 2,430 - - 170,674
2025-09-30 Raykov Rosty Director 限制性股票授予 (RSU) 5,208 - - 92,501
2025-09-05 Raykov Rosty Director 期权行权 36,207 $2.45 $88.71K 87,293
2025-09-04 Raykov Rosty Director 知情卖出 10,000 $8.92 $89.2K 51,086
2025-08-31 Andrade Robert Chief Financial Officer 限制性股票授予 (RSU) 2,431 - - 168,244
2025-08-31 Raykov Rosty Director 限制性股票授予 (RSU) 5,208 - - 61,086
■ 知情交易 — 公开市场买卖（最具参考价值） ■ 非知情买入 — 奖励、期权行权、转换 ■ 非知情卖出 — 税务代扣、归属出售 ■ 中性 — 礼赠、信托、到期

其他人也在看

EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
 IRON
IRON
Disc Medicine, Inc.
$70.48
+2.95%
 HRMY
HRMY
Harmony Biosciences Holdings, Inc.
$29.29
+0.83%
 OLMA
OLMA
Olema Pharmaceuticals, Inc.
$16.30
+2.32%
 JANX
JANX
Janux Therapeutics, Inc.
$15.24
+2.28%
 IKNA
IKNA
Ikena Oncology, Inc.
$17.16
+1,152.55%
 KROS
KROS
Keros Therapeutics, Inc.
$11.55
+3.59%
 LRMR
LRMR
Larimar Therapeutics, Inc.
$4.87
+0.21%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值，发现被低估的股票。
每周在线课程
📧 [email protected]
📞 +65 8912 8000
给我们留言